WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (148)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cadas, H.
Right arrow Articles by Piomelli, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cadas, H.
Right arrow Articles by Piomelli, D.

 Previous Article  |  Next Article 

Volume 16, Number 12, Issue of June 15, 1996 pp. 3934-3942
Copyright ©1996 Society for Neuroscience

Biosynthesis of an Endogenous Cannabinoid Precursor in Neurons and its Control by Calcium and cAMP

Hugues Cadas1, Sylvie Gaillet2, Massimiliano Beltramo1, Laurent Venance2, and Daniele Piomelli1

1 The Neurosciences Institute, San Diego, California 92121, and 2 Institut National de la Santé et de la Recherche Médicale, Paris, France

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES

ABSTRACT

Understanding the mechanisms involved in the biogenesis of N-arachidonoylethanolamine (anandamide) and Npalmitoylethanolamine is important in view of the possible role of these lipids as endogenous cannabinoid substances. Anandamide (which activates cannabinoid CB1 receptors) and N-palmitoylethanolamine (which activates a CB2-like receptor subtype in mast cells) may both derive from cleavage of precursor phospholipid, N-acylphosphatidylethanolamine (NAPE), catalyzed by Ca2+-activated D-type phosphodiesterase activity. We report here that the de novo biosynthesis of NAPE is enhanced in a Ca2+-dependent manner when rat cortical neurons are stimulated with the Ca2+-ionophore ionomycin or with membrane-depolarizing agents such as veratridine and kainate. This reaction is likely to be mediated by a neuronal N-acyltransferase activity, which catalyzes the transfer of an acyl group from phosphatidylcholine to the ethanolamine moiety of phosphatidylethanolamine. In addition, we show that Ca2+-dependent NAPE biosynthesis is potentiated by agents that increase cAMP levels, including forskolin and vasoactive intestinal peptide. Our results thus indicate that NAPE levels in cortical neurons are controlled by Ca2+ ions and cAMP. Such regulatory effect may participate in maintaining a supply of cannabimimetic N-acylethanolamines during synaptic activity, and prime target neurons for release of these bioactive lipids.

Key words: anandamide; N-acylethanolamines; phosphatidylethanolamine; N-acylphosphatidylethanolamine; N-acyltransferase; vasoactive intestinal peptide; endogenous cannabinoids

INTRODUCTION

There is evidence that N-arachidonoylethanolamine (anandamide) and other N-acylethanolamines (NAEs) act as intercellular signaling molecules in neural and non-neural tissues. Anandamide activates CB1-type cannabinoid receptors in brain and mimics many distinctive psychotropic effects typical of cannabinoid drugs (Devane et al., 1992) (for review, see Mechoulam et al., 1994). Similar effects are produced by other polyunsaturated NAEs (Hanus et al., 1993). In addition, anandamide may have effects that are independent of the stimulation of CB1 and CB2 receptors. In striatal astrocytes, anandamide selectively decreases gap-junction permeability, but this effect is not mimicked by cannabinoid drugs and it is not prevented by a CB1-receptor antagonist (Venance et al., 1995). Saturated NAEs may also be biologically active and, in some cases, participate in cannabimimetic signaling. For instance, N-palmitoylethanolamine activates a CB2-like cannabinoid receptor present on mast cells (Facci et al., 1995).

Biochemical evidence indicates that endogenous NAEs are produced in and released from neurons in a Ca2+- and activity-dependent manner (Di Marzo et al., 1994; Hansen et al., 1995). Furthermore, as expected for a signaling molecule, anandamide is short-lived: its lifespan is limited by uptake into neural cells (Di Marzo et al., 1994) and by enzymatic hydrolysis, catalyzed by a selective amidohydrolase activity (Desarnaud et al., 1995; Hillard et al., 1995; Ueda et al., 1995).

Two molecular mechanisms have been proposed for the generation of anandamide and other NAEs. The energy-independent condensation of ethanolamine and fatty acid has been reported (Colodzin et al., 1963; Deutsch and Chin, 1993; Devane and Axelrod, 1994; Kruszka and Gross, 1994). This reaction, which requires high concentrations of ethanolamine and fatty acid as well as alkaline pH optima, may be catalyzed by anandamide amidohydrolase acting in reverse (Ueda et al., 1995). Alternatively, anandamide and other NAEs may be produced by Ca2+-stimulated, phosphodiesterase-mediated cleavage of N-acylphosphatidylethanolamine (NAPE), a biochemical pathway extensively studied by Schmid and collaborators before the discovery of anandamide (for review, see Schmid et al., 1990).

In the present study, we used rat cortical neurons in primary culture to address three questions relevant to the role of NAPE as precursor for NAEs. In which brain cell types does NAPE biosynthesis occur? Is NAPE biosynthesis regulated by neural activity or by stimulation of neurotransmitter receptors? What enzymatic mechanisms underlie NAPE biosynthesis? Our results indicate that NAPE is synthesized in neurons, not in astrocytes, and that NAPE biosynthesis is controlled by intracellular Ca2+ levels ([Ca2+]i). Rises in [Ca2+]i lead to the stimulation of an N-acyltransferase activity that catalyzes the transfer of an acyl group from phosphatidylcholine (PC) to the ethanolamine moiety of phosphatidylethanolamine (PE), producing NAPE. Finally, our results show that NAPE biosynthesis is potentiated by agents that stimulate cAMP formation in neurons, including vasoactive intestinal peptide (VIP).

MATERIALS AND METHODS

Materials. NAPE (1-palmitoyl,2-oleoyl-sn-glycerol-3-phosphoethanolamine-N-arachidonoyl), PE, PC, sphingomyelin, and cerebrosides were obtained from Avanti Polar Lipids (Alabaster, AL); diacylglycerols, triacylglycerols, monoacylglycerols, cholesterol, and free fatty acids were from Nu-Chek Prep (Elysian, MN); calmidazolium, chelerythrine, 1,8-dideoxyforskolin, forskolin, KN-62, and 4-beta -phorbol-myristate-acetate were from Research Biochemicals (Natick, MA); ionomycin was from Boehringer Mannheim (Indianapolis, IN), and vasoactive intestinal peptide was from Calbiochem (La Jolla, CA); [3H]ethanolamine, [3H]arachidonic acid, [14C]arachidonic acid, and [3H]palmitic acid were from Amersham (Arlington Heights, IL); [3H]oleic acid and [14C]oleoyl-coenzyme A were from American Radiolabeled Products (St. Louis, MO); all other chemicals were from Sigma (St. Louis, MO). Cyclosporine was a generous gift of Sandoz Pharma (Basel, Switzerland).

Cell cultures and incubations. Cortical neuron and astrocyte cultures were prepared from 17-d-old rat embryos and maintained in serum-supplemented culture medium, as described previously (Di Marzo et al., 1994). Cortical neurons were used after 5-6 d in vitro. Neurons (90 mm dishes, plated at a density of 2.5 × 107 cells/dish) and astrocyte cultures (90 mm dishes, used at confluence) were labeled by incubation (16-20 hr) with [3H]ethanolamine (1 µCi/ml, 34 Ci/mmol), [3H]arachidonic acid (1 µCi/ml, 40-60 Ci/mmol), [14C]arachidonic acid (1 µCi/ml, 58 mCi/mmol), or [3H]palmitic acid (1 µCi/ml, 40-60 Ci/mmol). The cultures were rinsed with DMEM (Gibco, Grand Island, NY) and incubated for various times (10 min in typical experiments) in DMEM (5 ml) containing drugs at the indicated concentrations. Incubations were stopped by adding ice-cold methanol (2 ml).

Lipid extraction and analyses. The methanol-containing samples were extracted with chloroform (2 ml), and the chloroform extracts were subjected to open-bed chromatography on 1 ml silica gel G-columns. The NAPE-containing fractions [eluted with chloroform/methanol, 6:4 (v/v)] were analyzed by thin-layer chromatography (TLC, Analtech) using a solvent system of chloroform/methanol/ammonium hydroxide (80:20:1). In some experiments, bands (1 cm) were cut and radioactivity was measured by liquid scintillation counting. In other experiments, the radioactive lipids were fractionated by bidimensional TLC (system 1: chloroform/methanol/ammonium hydroxide/water, 65:25:4:1; system 2: chloroform/acetone/methanol/acetic acid/water, 30:40:10:7:5), visualized by autoradiography (Kodak XAR-5 film, 7 d exposure), and identified by comigration with authentic standards [visualized by spraying the plates with a solution of phosphomolybdic acid in ethanol, 10% (w/v)]. For quantitative analyses, NAPE-containing fractions obtained by open-bed column chromatography were subjected to further purification by reversed-phase HPLC on a µBondapak C18 column (Waters, Milford, MA) using a gradient of water in methanol (from 30 to 0% over 10 min). This HPLC system allowed us to resolve NAPE (retention time, ~14 min) from the following lipid components, which may be present in the NAPE-containing fractions: PE, PC, sphingomyelin, cerebrosides, diacylglycerols, triacylglycerols, monoacylglycerols, and cholesterol. NAPE differing in the N-acyl group were not resolved. The HPLC column was connected to an evaporative light-scattering detector (Eurosep) (for review, see Christie, 1987) with photomultiplier voltage set at 800 V and nebulization temperature set at 90°C. Under these conditions, we found that the photomultiplier response was linear between 1 and 10 µg of injected synthetic NAPE (Fig. 2d). Each HPLC analysis was carried out on pooled extracts from two dishes of neuronal cultures. In some experiments, the NAE-containing fractions from open-bed chromatography (eluted with chloroform/methanol, 9:1) were analyzed by normal-phase HPLC on a Resolve silica column (Waters) using a gradient of isopropanol in n-hexane (from 0 to 20% over 20 min). All NAEs were eluted from the column at a retention time of ~12 min. One minute fractions were collected during elution, and radioactivity was determined by liquid scintillation counting.

Fig. 2. Quantitative analysis of neuronal NAPE by HPLC coupled to evaporative light-scattering detection. Representative chromatograms from (a) control neurons, (b) 1 µM ionomycin-stimulated neurons, and (c) control neurons to which synthetic NAPE (10 µg) was added before extraction, to verify its HPLC coelution with native NAPE. The arrows indicate the retention time of synthetic NAPE. Lipids were extracted and fractionated by column chromatography. The NAPE-containing fractions from two culture dishes were pooled and subjected to reversed-phase HPLC, as described in Materials and Methods. d, Response of the light-scattering detector as a function of injected synthetic NAPE (in 40 µl of chloroform). Photomultiplier voltage was set at 800 V, and nebulization temperature was set at 90°C.
[View Larger Version of this Image (21K GIF file)]

NAPE biosynthesis in neuronal homogenates. N-acyltransferase assays were performed in 50 mM Tris buffer, pH 7.4, containing protein (4 mg/ml), 0.1% Triton X-100 (TX-100), 3 mM CaCl2, or 10 mM EGTA and [14C]dioleoyl-PC or [14C]dipalmitoyl-PC (1 µCi/ml, 80-120 mCi/mmol). After 1 hr of incubation, reactions were stopped with methanol and the lipid was extracted. The samples were applied to silica gel G-columns, [14C]NAPE-containing fractions were eluted with chloroform/methanol (6:4), and radioactivity in the fractions was measured by liquid scintillation counting. Unreacted [14C]PC was eluted with 100% methanol. In initial experiments, we confirmed the identity of the radioactive material eluting from the silica gel G-columns as [14C]NAPE by bidimensional TLC as described above (data not shown). Incubations with [3H]oleic acid (60 Ci/mmol) and [14C]oleoyl-coenzyme A (55 mCi/mmol) were carried out for 1 hr in 50 mM Tris buffer, pH 7.4, containing protein (4 mg/ml) plus one or a combination of the following: 3 mM CaCl2, 10 mM EGTA, and 0.1% TX-100. After extraction, the radioactive lipids were fractionated on silica gel G-columns and analyzed by monodimensional TLC, as described above.

Intracellular [Ca2+]i and cAMP measurements. Intracellular [Ca2+]i measurements were performed by dual-emission microfluorimetry using the fluorescent dye Indo 1-AM, and [Ca2+]i concentrations were calculated from the fluorescence ratio (measured at 410 and 480 nm) using a Kd of 250 nM for Indo 1-AM (Grynkiewicz et al., 1985; Venance et al., 1995). cAMP was measured by ELISA using a commercial kit (Amersham) and following the manufacturer's instructions.

Statistical analyses. Results are expressed as the mean ± SEM of n experiments, and statistical significance was determined by ANOVA.

RESULTS

The Ca2+ ionophore ionomycin is potent in increasing [3H]NAPE levels in primary cultures of rat cortical neurons labeled to apparent isotopic equilibrium with [3H]ethanolamine (Fig. 1a). This effect is (1) dependent on the presence of extracellular Ca2+ ions, as shown by the ability of EGTA (10 mM) to prevent it (Fig. 1 b); (2) dependent on the concentration of ionomycin (Fig. 1b, inset); (3) restricted to neurons: NAPE is prominently labeled in ionomycin-stimulated neurons (Fig. 1c), whereas only background radioactivity comigrates with NAPE in ionomycin-stimulated astrocytes (Fig. 1 d); (4) time-dependent and significant after a 4 min incubation with ionomycin (data not shown). Under identical conditions, ionomycin (1 µM) stimulates [3H]NAE formation in cortical and striatal neurons (Di Marzo et al., 1994).
Fig. 1. Biosynthesis of [3H]NAPE in primary cultures of rat brain cortical neurons. a, Ionomycin (1 µM, 10 min) stimulates [3H]NAPE biosynthesis in neurons labeled by incubation with [3H]ethanolamine (Eth), [3H]arachidonic acid (AA), or [3H]palmitic acid (PA). NAPE was fractionated by column chromatography, and NAPE-containing fractions were analyzed by monodimensional TLC. Results are expressed as mean ± SEM (dpm/dish) of six separate experiments. b, The effect of ionomycin is prevented by chelating extracellular Ca2+ with EGTA (10 mM) and is concentration-dependent (inset, µM concentrations). In these experiments, the neurons were labeled with [3H]ethanolamine. c, d, Ionomycin stimulates NAPE biosynthesis in neurons (c), but not in astrocytes (d). Cultures were labeled by overnight incubation with [14C]arachidonic acid. NAPE was analyzed by bidimensional TLC and autoradiography. On these representative chromatograms, the numbers indicate the positions of the following lipids: (1) NAPE; (2) unknown; (3) cerebrosides; (4) PE; (5) PC; (6) phosphatidylserine plus phosphatidylinositol. O, Origin.
[View Larger Version of this Image (87K GIF file)]

The observed increase in [3H]ethanolamine-labeled NAPE may reflect either a de novo biosynthesis of the phospholipid or an increased turnover in its ethanolamine-containing moiety, expected from the stimulation of a D-type phosphodiesterase activity (Di Marzo et al., 1994). Two findings support the possibility that de novo biosynthesis contributes to the observed effect. First, ionomycin produces equivalent effects in neurons labeled with two additional radioactive NAPE precursors, [3H]palmitic acid and [3H]arachidonic acid, which are expected to be preferentially incorporated into distinct moieties of NAPE ([3H]palmitic acid into the sn-1 position, and [3H]arachidonic acid into the sn-2 position; Fig. 1a). Second, mass analysis of NAPE by HPLC coupled to light-scattering detection reveals that neurons contain 0.77 ± 0.13 µg of NAPE/dish when unstimulated, and 1.4 ± 0.2 µg/dish when stimulated with ionomycin (n = 4; Fig. 2a,b). The HPLC fractionation used here provides both a reliable method for identifying unlabeled NAPE (Fig. 2c and Materials and Methods) and a sensitive approach to the quantification of this lipid in the mass range present in cultured neurons (Fig. 2d).

We determined the [Ca2+]i at which ionomycin stimulates NAPE biosynthesis by using the Ca2+-sensitive dye Indo 1-AM. Ionomycin (1 µM) evokes in ~30% of the neurons a slow oscillatory rise in [Ca2+]i (data not shown). In responding neurons (51/170), [Ca2+]i increases on average from a basal level of 35 ± 4 to 154 ± 16 nM after a 10 min incubation with ionomycin. Such [Ca2+]i responses, well within those caused by neuronal activity, prompted us to study the effects of membrane-depolarizing agents on NAPE biosynthesis.

Application of the Na+-channel activator veratridine (20 µM) produces in 81% of the neurons a [Ca2+]i rise (basal, 40 ± 1 nM; 20 sec, 255 ± 11 nM; 10 min, 120 ± 1 nM; n = 183). In identical experiments, veratridine produced a significant increase in [3H]NAPE biosynthesis (Fig. 3a). The latter is prevented by EGTA (10 mM) or tetrodotoxin (1 µM), confirming the participation of extracellular Ca2+ and Na+ channels, respectively (Fig. 3a). We observed similar increases in [3H]NAPE with two K+-channel blockers (4-aminopyridine and 3,4-diaminopyridine, both at 3 mM) and with a glutamate-receptor agonist (kainate, 0.1 mM; Fig. 3a). In the same experiments, we also measured [3H]NAE formation and found that it was enhanced (Fig. 3b), as expected from previous results (Di Marzo et al., 1994; Hansen et al., 1995). It should be noted that ionomycin is more efficacious than veratridine in enhancing NAPE biosynthesis, although it produces a smaller effect on [Ca2+]i: differences in the kinetics or subcellular localization of the [Ca2+]i changes evoked by the two drugs might account for this discrepancy.

Fig. 3. Effects of various depolarizing agents on [3H]NAPE biosynthesis and [3H]NAE formation in cortical neurons. a, [3H]NAPE biosynthesis: veratridine (20 µM), 4-aminopyridine (4-AP; 3 mM), 3,4-diaminopyridine (3,4-AP; 3 mM), and kainate (0.1 mM). EGTA and tetrodotoxin (TTX) were used at 10 mM and 1 µM, respectively. b, [3H]NAE formation was determined in the same or parallel experiments. The ability of 4-AP, 3,4-AP, and kainate to stimulate [3H]NAE formation was documented previously (Di Marzo et al., 1994). The effect of ionomycin (1 µM, 10 min) is shown for comparison. Results are expressed as percent of control and represent the mean ± SEM of five to eight separate experiments; *p < 0.05, ***p < 0.001 (ANOVA); NS, nonsignificantly different from unstimulated cultures.
[View Larger Version of this Image (24K GIF file)]

Many neuronal actions of Ca2+ are mediated by stimulation of Ca2+/calmodulin-dependent protein kinases and phosphatases (Walaas and Greengard, 1987; Hanson and Schulman, 1992). We found, however, that inhibiting calmodulin with calmidazolium (200 µM), Ca2+/calmodulin-dependent protein kinase II with KN-62 (10 µM), or calcineurin with cyclosporine (200 µM) did not affect ionomycin-induced [3H]NAPE biosynthesis (Table 1). Protein kinase C (PKC) is also unlikely to be involved, because the PKC activator 4-beta -phorbol-myristate acetate (PMA, 1 µM) neither mimics nor potentiates the effect of ionomycin, and the PKC blocker chelerythrine inhibits it only partially even when used at a supramaximal concentration (5 µM; Table 1).

Table 1. Effects of various pharmacological agents on [3H]NAPE formation in cortical neurons in primary culture

Drug Concentration (µM) [3H]NAPE (% of control ± SEM)
Ionomycin 1 100
+ Calmidazolium 200 112  ± 3  (n = 3)
+ KN-62 10 104  ± 28  (n = 12)
+ Cyclosporin 200 150  ± 15  (n = 6)
+ PMA 1 99  ± 10  (n = 3)
+ Chelerythrin 5 71  ± 5  (n = 6)
PMA alone 1 101  ± 6  (n = 11)
Assays were carried out as described in Materials and Methods. Kinase and phosphatase inhibitors were added to the incubation media 10-15 min before stimulation. In the presence of ionomycin (1 µM), radioactivity in [3H]NAPE was 17,100 ± 2116 dpm/dish (n = 20).

In contrast with PMA, the adenylyl cyclase activator forskolin (10 µM) is potent in enhancing ionomycin-induced [3H]NAPE accumulation (Fig. 4). Pharmacological experiments indicate that this response is mediated by cAMP: the potentiating effect of forskolin is not mimicked by the inactive forskolin analog 1,8-dideoxyforskolin (10 µM; data not shown) and is prevented by the selective cAMP-dependent protein kinase inhibitor H-89 (0.5 µM; Fig. 4). When applied alone, forskolin has no effect on [3H]NAPE levels (Fig. 4).

Fig. 4. Potentiation of ionomycin (iono)-stimulated [3H]NAPE biosynthesis by forskolin (FSK; 10 µM) and vasoactive intestinal peptide (VIP; 1 µM) in cortical neurons. ***p < 0.001; a, versus control; b, versus ionomycin; NS, nonsignificant.
[View Larger Version of this Image (33K GIF file)]

The neuroactive peptide VIP is thought to acts as a neuronal messenger in mammalian cortex (Giachetti et al., 1977; Quick et al., 1978; Magistretti and Morrison, 1988). VIP binds to VIP-type and to pituitary adenylyl-cyclase activating peptide (PACAP)-type receptors, which are both positively coupled to adenylyl cyclase activity (Ishihara et al., 1992; Hashimoto et al., 1993). We found that application of VIP (1 µM) enhances ionomycin-evoked [3H]NAPE biosynthesis (Fig. 4). This effect is (1) half-maximal at 400 ± 42 nM VIP (n = 2); (2) accompanied by increased cAMP levels (half-maximal at 300 ± 53 nM VIP; n = 6; data not shown); (3) prevented by inhibiting cAMP-dependent protein kinase activity with H-89 (Fig. 4). Like forskolin, VIP has no effect on [3H]NAPE levels when applied alone (Fig. 4). Importantly, VIP also potentiated ionomycin-evoked formation of [3H]NAEs. In three experiments, cortical neurons produced 145 ± 12 dpm/dish of [3H]NAEs under control conditions, 290 ± 14 dpm/dish with ionomycin (1 µM), 223 ± 47 dpm/dish with VIP alone (1 µM), and 510 ± 90 dpm/dish with VIP plus ionomycin.

VIP-containing neurons in the cortex are also thought to secrete acetylcholine (Magistretti and Morrison, 1988). However, carbachol (1 mM), a cholinergic-receptor agonist, has no effect on the levels of [3H]NAPE or [3H]NAEs when applied either alone or in combination with 1 µM ionomycin (data not shown).

Experimental evidence suggests that NAPE may be produced by enzymatic N-acylation of PE (Hazlewood and Dawson, 1975; Schmid et al., 1990; Chapman and Moore, 1993). Two possible acyl group donors have been postulated to participate in this reaction: glycerophospholipids, in bacteria and animal tissues (Hazlewood and Dawson, 1975; Schmid et al., 1990), and free fatty acids, in plant tissues (Chapman and Moore, 1993). Another acyl donor, fatty acyl-coenzyme A, participates in the N-acylation of sphinganine to N-acylsphinganine, a key step in the pathway of ceramide biosynthesis (Kishimoto, 1983). Homogenates of cortical neurons produce [14C]NAPE when they are incubated in the presence of [14C]PC and Ca2+ (3 mM; Fig. 5a), whereas we observed no [14C]NAPE synthesis in neuron homogenates incubated with EGTA (10 mM; Fig. 5b), or in astrocyte homogenates incubated with 3 mM Ca2+ (data not shown). By using an assay based on open-bed chromatography, we confirmed that [14C]NAPE formation is calcium-dependent and, as expected of an enzymatic mechanism, sensitive to heating (Fig. 5c). In contrast with the results obtained with [14C]PC, we found that neither [14C]oleoyl-coenzyme A nor [3H]oleic acid or [14C] palmitic acid is incorporated into NAPE under various experimental conditions (Table 2).

Fig. 5. Ca2+-dependent [14C]NAPE formation and N-acyltransferase activity in homogenates of cortical neurons. Homogenates were incubated with [14C]dioleoyl-PC or [14C]dipalmitoyl-PC in the presence of either Ca2+ (3 mM) (a) or 10 mM EGTA (b). The incubation mixtures were subjected to lipid extraction and analyzed by bidimensional TLC. Radioactivity on the plates was visualized with a PhosphorImager. c, N-acyltransferase activity in neuron homogenates. Assay conditions and analysis by column chromatography are described in Materials and Methods. Results (mean ± SEM) are from one experiment, performed in triplicate and typical of four experiments.
[View Larger Version of this Image (9K GIF file)]

Table 2. NAPE biosynthesis in homogenates of neuronal cultures: lack of incorporation of labeled fatty acids or oleoyl CoA

Conditions [14C]palmitic acid (dpm ± SEM; n = 3) [3H]oleic acid (dpm; n = 2) [14C]oleoyl CoA (dpm; n = 2)
Tissue 864  ± 149 ND ND
Boiled tissue 790  ± 184 375 90
+ Ca2+ 528  ± 57 452 87
+ EGTA ND 297 38
+ TX-100 477  ± 66 ND ND
+ Ca2+, TX-100 358  ± 11 ND ND
+ Ca2+, TX-100, EGTA 543  ± 11 ND ND
Homogenates were incubated for 1 h at 37°C in 50 mM Tris, pH 7.4, containing one or more of the following: Ca2+ (3 mM), EGTA (10 mM), TX-100 (0.1%, v/v). Results are from one experiment, representative of two experiments performed in triplicate with [14C]palmitic acid, and from two experiments with [3H]oleic acid and [14C]oleoyl CoA.

DISCUSSION

A possible biochemical mechanism for the formation of biologically active NAEs, including anandamide, is the hydrolytic cleavage of the phospholipid precursor NAPE, a minor N-acylated derivative of PE. This mechanism, illustrated schematically in Figure 6, postulates that stimulus-dependent rises in [Ca2+]i activate a D-type phosphodiesterase activity (phospholipase D) that catalyzes NAPE hydrolysis. Because NAPE is composed of multiple molecular species differing in the fatty acyl moiety linked to PE, the phosphodiesterase reaction results in the mobilization of a family of different NAEs. We do not fully understand yet the biological roles of this heterogeneous family of lipid molecules. We know, however, that several NAEs share the ability to bind to and activate cannabinoid receptors: in brain and in peripheral tissues, anandamide and other polyunsaturated NAEs activate CB1-type receptors (for review, see Mechoulam et al., 1994), whereas in mastocytes and in mastocyte-derived cell lines, N-palmitoylethanolamine activates a CB2-like receptor subtype (Facci et al., 1995). Such pleiotropic properties of the NAEs are reminiscent of another lipid-signaling family, the eicosanoids, which are generated from a single precursor molecule, arachidonic acid, and activate multiple transmembrane receptors (for review, see Piomelli, 1994).
Fig. 6. Model of biosynthesis and regulation of the endogenous cannabinoid precursor NAPE in rat cortical neurons. [Ca2+]i rises produced by neuronal depolarization may stimulate an N-acyltransferase activity that catalyzes the intermolecular transfer of a fatty acyl group from a glycerophospholipid [e.g., phosphatidylcholine (PC)], to the ethanolamine moiety of phosphatidylethanolamine (PE), forming NAPE and lysophospholipid (e.g., lyso PC). Neuromodulators (e.g., VIP) may enhance Ca2+-dependent NAPE biosynthesis by activating a membrane receptor (R) coupled to the activation of adenylyl cyclase (AC) and to the subsequent stimulation of cAMP-dependent protein kinase (PKA) activity. The broken arrow indicates that the molecular target of PKA leading to enhanced NAPE biosynthesis remains to be determined. NAPE is composed of several molecular species, differing in the fatty acyl group linked to the ethanolamine moiety (Schmid et al., 1990; Cadas et al., 1996). Therefore, cleavage of NAPE by a D-type phosphodiesterase activity [phospholipase D (PLD)] may give rise to multiple N-acylethanolamines (NAEs), including anandamide (which activates cannabinoid CB1-type receptors) and N-palmitoylethanolamine (which activates CB2-type receptors in certain cell types). Although cannabimimetic NAEs may be recovered in the extracellular fluid of stimulated neurons in culture (Di Marzo et al., 1994; Hansen et al., 1995), the mechanism of extrusion of these lipids (indicated schematically as a broken arrow) is still unknown.
[View Larger Version of this Image (24K GIF file)]

Several lines of evidence support the biochemical mechanism of NAE formation illustrated in Figure 6. The spectrum of NAEs recovered after stimulation of neurons in primary culture closely corresponds to that expected from the N-acyl moiety composition of neuronal NAPE. Further, stimulus-dependent formation of NAEs is accompanied by increased NAPE turnover. Even further, neuron homogenates contain an enzymatic activity that catalyzes the hydrolysis of radiolabeled NAPE, producing anandamide and other NAEs (Di Marzo et al., 1994; Cadas et al., 1996). Although this evidence supports a role of NAPE as NAE precursor, it does not rule out the possibility that additional, independent pathways of anandamide formation may exist. This is suggested by the ability of brain homogenates to catalyze the energy-independent formation of anandamide from nonesterified arachidonate and ethanolamine (Deutsch and Chin, 1993; Devane and Axelrod, 1994; Kruszka and Gross, 1994), a reaction that may be carried out by the reverse reaction of the degradative enzyme anandamide amidohydrolase (Ueda et al., 1995).

Prompted by the possible role of NAPE as NAE precursor, in the present study we have addressed a series of questions pertinent to the control of NAPE biosynthesis in brain tissue. Is the biosynthesis of NAPE regulated? And, if so, in which cell types and through what mechanism? The main results of our study are summarized in Figure 6.

We found that substances that stimulate NAE formation---including the Ca2+ ionophore ionomycin and several chemically unrelated membrane depolarizing agents (Di Marzo et al., 1994) (present study)---are also effective in increasing the de novo biosynthesis of NAPE in cortical neurons in primary culture (Figs. 1, 2, 3). By contrast, we could not detect NAPE or stimulus-induced NAPE biosynthesis in cortical astrocyte cultures (Fig. 1d). A parsimonious interpretation of our results is that NAPE biosynthesis is restricted to neurons. We cannot exclude, however, the possibility that cultured astrocytes lose the enzymatic complement necessary to the formation of this phospholipid.

Stimulus-induced NAPE biosynthesis is Ca2+-dependent and occurs at [Ca2+]i (120-150 nM) that are compatible with physiological stimulations (see Petrozzino et al., 1995). This result leads us to speculate that, during prolonged nerve activity, Ca2+-dependent NAPE biosynthesis may participate in replenishing the stores of NAPE depleted by phosphodiesterase-mediated formation of NAEs. Such a mechanism would be functionally analogous to that operative at monoaminergic synapses, where electrical activity evokes the Ca2+-dependent phosphorylation and consequent activation of tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis (Zigmond and Bowers, 1981; El Mestikawi et al., 1985).

Unlike the case of tyrosine hydroxylase, however, the regulation of NAPE biosynthesis by Ca2+ does not appear to involve calmodulin-dependent protein kinases or PKC, as suggested by the lack of effect of various pharmacological inhibitors of these kinases (Table 1). An alternative possibility, namely, that Ca2+ ions may act to stimulate NAPE biosynthesis directly, is supported by the existence in neurons of a Ca2+-dependent N-acyltransferase activity (Fig. 5), absent from cultured astrocytes, which may catalyze the formation of NAPE via intermolecular transfer of a fatty acyl group from glycerophospholipid to the ethanolamine moiety of PE (Fig. 6). Such an activity was described previously in dog brain tissue, but its cellular localization and physiological regulation has remained elusive thus far (Natarajan et al., 1983; Schmid et al., 1990). Moreover, the results illustrated in Table 2 appear to rule out the participation in neuronal NAPE biosynthesis of other known mechanisms of amino group N-acylation, including those implicated in the synthesis of NAPE in higher plants (Chapman and Moore, 1993) and of N-acylsphinganine in mammalian tissues (Kishimoto, 1983). While this study was under review, a similar N-acyltransferase activity was also described in rat testis (Sugiura et al., 1996).

Although protein phosphorylation is not likely to mediate Ca2+-dependent NAPE biosynthesis, our results suggest that it may exert an important modulatory function. This possibility is suggested by the marked potentiation that forskolin and VIP produce on the ionomycin-induced accumulation of NAPE (Fig. 4). In particular, we found that the potentiating effect of VIP occurs at concentrations (EC50 = 400 ± 42 nM) similar to those required to activate adenylyl cyclase in cortical neurons (EC50 = 300 ± 53 nM), and is prevented by the cAMP-dependent protein kinase inhibitor H-89. The results indicate therefore that VIP, interacting with either VIP or PACAP receptor subtypes, potentiates Ca2+-dependent NAPE biosynthesis by stimulating cAMP-dependent protein kinase activity. Thus, VIP-secreting neurons in the cortex, and possibly other brain modulatory systems positively linked to cAMP production, may participate with Ca2+ in a priming mechanism the consequence of which would be to increase the availability of NAPE for release of cannabimimetic NAEs. It will be important to determine whether a priming mechanism, such as that suggested here for cultured neurons, occurs also in the adult brain and plays a role in the functional interactions between cannabinoids and cAMP-linked brain reward systems (for review, see Gardner, 1992).

FOOTNOTES

Received Feb. 14, 1996; revised March 27, 1996; accepted April 1, 1996.

  

Initial experiments were carried out at the Centre Paul Broca of Institut National de la Santé et de la Recherche Médicale, Paris, France, and the support of Prof. J.-C. Schwartz is gratefully acknowledged. We thank Drs. Joseph Gally and Nephi Stella for reading this manuscript critically, Dr. Emmanuelle di Tomaso for discussion, and Prof. S. Yamamoto, Prof. H. S. Hansen, and their colleagues for sharing results before publication.

Correspondence should be addressed to Daniele di Piomelli, The Neurosciences Institute, 10640 John J. Hopkins Drive, San Diego, CA 92121.

Dr. Gaillet's present address: Laboratoire de Neurobiologie et Endocrinologie, CNRS URA 1197, Montpellier, France.


REFERENCES

  • Cadas H, Schinelli S, Piomelli D (1996) Membrane localization of N-acylphosphatidylethanolamine in central neurons: studies with exogenous phospholipases. J Lipid Med, in press.
  • Chapman K, Moore JT (1993) Catalytic properties of a newly discovered acyltransferase that synthesizes N-acylphosphatidylethanolamine in cottonseed (Gossipuim hirsutum L.) microsomes. Plant Physiol 102:761-769. [Abstract]
  • Colodzin M, Bachur N, Weissbach H, Udenfriend S (1963) Enzymatic formation of fatty acid amides of ethanolamine by rat liver microsomes. Biochem Biophys Res Commun 10:165-170.
  • Christie W (1987) HPLC and lipids: a practical guide, pp 23-25. .
  • Desarnaud F, Cadas H, Piomelli D (1995) Anandamide amidohydrolase activity in rat brain microsomes: identification and partial characterisation. J Biol Chem 270:6030-6035 . [Abstract/Free Full Text]
  • Deutsch D, Chin S (1993) Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol 46:791-796 . [Web of Science][Medline]
  • Devane W, Axelrod J (1994) Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. Proc Natl Acad Sci USA 91:6698-6701 . [Abstract/Free Full Text]
  • Devane W, Hanus L, Breuer A, Pertwee R, Stevenson L, Griffin G, Gibson D, Mandelbaum D, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949 . [Abstract/Free Full Text]
  • Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz J-C, Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372:686-691 . [Medline]
  • El Mestikawi S, Gozlan H, Glowinski J, Hamon M (1985) Characteristics of tyrosine hydroxylase activation by K+-induced depolarization and/or forskolin in rat striatal slices. J Neurochem 45:173-184. [Web of Science][Medline]
  • Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A (1995) Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamine. Proc Natl Acad Sci USA 92:3376-3380 . [Abstract/Free Full Text]
  • Gardner E (1992) Marijuana/cannabinoids: neurobiology and neurophysiology. In: CRC series in physiology of drug abuse (Bartke, LMA, eds) , p. 275. Boca Raton, FL: CRC.
  • Giachetti A, Said S, Reynolds R, Koniges S (1977) Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals. Proc Natl Acad Sci USA 74:3424-3428 . [Abstract/Free Full Text]
  • Grynkiewicz G, Poenie M, Tsien R (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450 . [Abstract/Free Full Text]
  • Hansen H, Lauritzen L, Mette Strand A, Moesgaard B, Frandsen A (1995) Glutamate stimulates the formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cortical neurons in culture. BBA 1258:303-308.
  • Hanson P, Schulman H (1992) Neuronal Ca2+/calmodulin-dependent protein kinases. Annu Rev Biochem 61:559-601 . [Web of Science][Medline]
  • Hanus L, Gopher A, Almog S, Mechoulam R (1993) Two new unsaturated fatty acid ethanolamines in brain that bind to the cannabinoid receptor. J Med Chem 36:3032-3034 . [Web of Science][Medline]
  • Hashimoto H, Ishihara T, Shigemoto R, Mori K, Nagata S (1993) Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide. Neuron 11:333-342 . [Web of Science][Medline]
  • Hazlewood G, Dawson M (1975) Intermolecular transacylation of phosphatidylethanolamine by a Butyrivibrio sp. Biochem J 150:521-525 . [Web of Science][Medline]
  • Hillard C, Wilkison D, Edgemond W, Campbell W (1995) Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. Biochem Biophys Res Commun 1257:249-256.
  • Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S (1992) Functional expression and tissue distribution of a novel receptor for vasoactive intestinal peptide. Neuron 8:811-819 . [Web of Science][Medline]
  • Kishimoto Y (1983) Sphingolipid formation. In: The enzymes (Boyer, PD, eds) , p. 363. New York: Academic.
  • Kruszka K, Gross R (1994) The ATP- and CoA-independent synthesis of arachidonoylethanolamine. J Biol Chem 269:14345-14348 . [Abstract/Free Full Text]
  • Magistretti P, Morrison J (1988) Noradrenaline- and vasoactive intestinal peptide-containing neuronal systems in neocortex: functional convergence with contrasting morphology. Neuroscience 24:367-378 . [Web of Science][Medline]
  • Mechoulam R, Hanus L, Martin B (1994) Search for endogenous ligands of the cannabinoid receptor. Biochem Pharmacol 48:1537-1544 . [Web of Science][Medline]
  • Natarajan V, Schmid P, Reddy P, Zuzarte-Augustin M, Schmid H (1983) Biosynthesis of N-acylethanolamine phospholipids by dog brain preparations. J Neurochem 41:1303-1312 . [Web of Science][Medline]
  • Petrozzino J, Pozzo Miller L, Connor J (1995) Micromolar Ca2+ transients in dendritic spines of hippocampal pyramidal neurons in brain slice. Neuron 14:1223-1231 . [Web of Science][Medline]
  • Piomelli D (1994) Eicosanoids in synaptic transmission. Crit Rev Neurobiol 8:65-83 . [Web of Science][Medline]
  • Quick M, Iversen L, Bloom S (1978) Effect of vasoactive intestinal peptide (VIP) and other peptides on cAMP accumulation in rat brain. Biochem Pharmacol 27:2209-2213. [Web of Science][Medline]
  • Schmid H, Schmid P, Natarajan V (1990) N-acylated glycerophospholipids and their derivatives. Prog Lipid Res 29:1-43 . [Web of Science][Medline]
  • Sugiura T, Kondo S, Sukagawa A, Tonegawa T, Nakane S, Yamashita A, Waku K (1996) Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: involvement of Ca2+-dependent transacylase and phosphodiesterase activities. Biochem Biophys Res Commun 218:113-117 . [Web of Science][Medline]
  • Ueda N, Kurahashi Y, Yamamoto S, Tokunaga T (1995) Partial purification and characterization of the porcine brain enzyme hydrolysing and synthetizing anandamide. J Biol Chem 270:23823-23827 . [Abstract/Free Full Text]
  • Venance L, Piomelli D, Glowinski J, Giaume C (1995) Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. Nature 376:590-593 . [Medline]
  • Walaas S, Greengard P (1987) Phosphorylation of brain proteins. In: The enzymes (Boyer, PD, eds) , p. 285. New York: Academic.
  • Zigmond R, Bowers C (1981) Influence of nerve activity on the macromolecular content of neurons and their effector organs. Annu Rev Physiol 43:673-673 . [Web of Science][Medline]
Copyright ©1996 Society for Neuroscience   0270-6474/1996/163934-9$05.00/0



This article has been cited by other articles:


Home page
 J. Neurosci.Home page
L. Orio, S. Edwards, O. George, L. H. Parsons, and G. F. Koob
A Role for the Endocannabinoid System in the Increased Motivation for Cocaine in Extended-Access Conditions
J. Neurosci., April 15, 2009; 29(15): 4846 - 4857.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. Marinelli, S. Pacioni, T. Bisogno, V. Di Marzo, D. A. Prince, J. R. Huguenard, and A. Bacci
The Endocannabinoid 2-Arachidonoylglycerol Is Responsible for the Slow Self-Inhibition in Neocortical Interneurons
J. Neurosci., December 10, 2008; 28(50): 13532 - 13541.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
G. Astarita, F. Ahmed, and D. Piomelli
Identification of biosynthetic precursors for the endocannabinoid anandamide in the rat brain
J. Lipid Res., January 1, 2008; 49(1): 48 - 57.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. LoVerme, M. Guzman, S. Gaetani, and D. Piomelli
Cold Exposure Stimulates Synthesis of the Bioactive Lipid Oleoylethanolamide in Rat Adipose Tissue
J. Biol. Chem., August 11, 2006; 281(32): 22815 - 22818.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
R. Malcher-Lopes, S. Di, V. S. Marcheselli, F.-J. Weng, C. T. Stuart, N. G. Bazan, and J. G. Tasker
Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release.
J. Neurosci., June 14, 2006; 26(24): 6643 - 6650.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
L. G. Bilsland, J. R. T. Dick, G. Pryce, S. Petrosino, V. Di Marzo, D. Baker, and L. Greensmith
Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice
FASEB J, May 1, 2006; 20(7): 1003 - 1005.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. Astarita, B. C. Rourke, J. B. Andersen, J. Fu, J. H. Kim, A. F. Bennett, J. W. Hicks, and D. Piomelli
Postprandial increase of oleoylethanolamide mobilization in small intestine of the Burmese python (Python molurus)
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2006; 290(5): R1407 - R1412.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. A. Moore, G. G. Nomikos, A. K. Dickason-Chesterfield, D. A. Schober, J. M. Schaus, B.-P. Ying, Y.-C. Xu, L. Phebus, R. M. A. Simmons, D. Li, et al.
From The Cover: Identification of a high-affinity binding site involved in the transport of endocannabinoids
PNAS, December 6, 2005; 102(49): 17852 - 17857.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. Gonzalez-Yanes, A. Serrano, F. J. Bermudez-Silva, M. Hernandez-Dominguez, M. A. Paez-Ochoa, F. R. de Fonseca, and V. Sanchez-Margalet
Oleylethanolamide impairs glucose tolerance and inhibits insulin-stimulated glucose uptake in rat adipocytes through p38 and JNK MAPK pathways
Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E923 - E929.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Tian, J. Guo, F. Yao, D.-P. Yang, and A. Makriyannis
The Conformation, Location, and Dynamic Properties of the Endocannabinoid Ligand Anandamide in a Membrane Bilayer
J. Biol. Chem., August 19, 2005; 280(33): 29788 - 29795.
[Abstract] [Full Text] [PDF]

Home page
 Alcohol AlcoholHome page
F. RODRIGUEZ de FONSECA, I. DEL ARCO, F. J. BERMUDEZ-SILVA, A. BILBAO, A. CIPPITELLI, and M. NAVARRO
THE ENDOCANNABINOID SYSTEM: PHYSIOLOGY AND PHARMACOLOGY
Alcohol Alcohol., January 1, 2005; 40(1): 2 - 14.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
J. Ronesi and D. M. Lovinger
Induction of striatal long-term synaptic depression by moderate frequency activation of cortical afferents in rat
J. Physiol., January 1, 2005; 562(1): 245 - 256.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. C. Azad, K. Monory, G. Marsicano, B. F. Cravatt, B. Lutz, W. Zieglgansberger, and G. Rammes
Circuitry for Associative Plasticity in the Amygdala Involves Endocannabinoid Signaling
J. Neurosci., November 3, 2004; 24(44): 9953 - 9961.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
G. Marsicano, S. Goodenough, K. Monory, H. Hermann, M. Eder, A. Cannich, S. C. Azad, M. G. Cascio, S. O. Gutierrez, M. van der Stelt, et al.
CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Science, October 3, 2003; 302(5642): 84 - 88.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
T. F. FREUND, I. KATONA, and D. PIOMELLI
Role of Endogenous Cannabinoids in Synaptic Signaling
Physiol Rev, July 1, 2003; 83(3): 1017 - 1066.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
W.-R. Schabitz, A. Giuffrida, C. Berger, A. Aschoff, M. Schwaninger, S. Schwab, and D. Piomelli
Release of Fatty Acid Amides in a Patient With Hemispheric Stroke: A Microdialysis Study
Stroke, August 1, 2002; 33(8): 2112 - 2114.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
J. Wang and R. S Zucker
Photolysis-induced suppression of inhibition in rat hippocampal CA1 pyramidal neurons
J. Physiol., June 15, 2001; 533(3): 757 - 763.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
T. A. Day, F. Rakhshan, D. G. Deutsch, and E. L. Barker
Role of Fatty Acid Amide Hydrolase in the Transport of the Endogenous Cannabinoid Anandamide
Mol. Pharmacol., June 1, 2001; 59(6): 1369 - 1375.
[Abstract] [Full Text]

Home page
 J. Neurosci.Home page
J. J. Rodriguez, K. Mackie, and V. M. Pickel
Ultrastructural Localization of the CB1 Cannabinoid Receptor in {micro}-Opioid Receptor Patches of the Rat Caudate Putamen Nucleus
J. Neurosci., February 1, 2001; 21(3): 823 - 833.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
R. Siman, A. G. Reaume, M. J. Savage, S. Trusko, Y.-G. Lin, R. W. Scott, and D. G. Flood
Presenilin-1 P264L Knock-In Mutation: Differential Effects on Abeta Production, Amyloid Deposition, and Neuronal Vulnerability
J. Neurosci., December 1, 2000; 20(23): 8717 - 8726.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
M. Beltramo, N. Stella, A. Calignano, S. Y. Lin, A. Makriyannis, and D. Piomelli
Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition
Science, August 22, 1997; 277(5329): 1094 - 1097.
[Abstract] [Full Text]

Home page
 BMJHome page
M. A Schuckit
Science, medicine, and the future: Substance use disorders
BMJ, May 31, 1997; 314(7094): 1605 - 1605.
[Full Text]

Home page
 J. Neurosci.Home page
H. Cadas, E. di Tomaso, and D. Piomelli
Occurrence and Biosynthesis of Endogenous Cannabinoid Precursor, N-Arachidonoyl Phosphatidylethanolamine, in Rat Brain
J. Neurosci., February 15, 1997; 17(4): 1226 - 1242.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Siman, D. G. Flood, G. Thinakaran, and R. W. Neumar
Endoplasmic Reticulum Stress-induced Cysteine Protease Activation in Cortical Neurons. EFFECT OF AN ALZHEIMER'S DISEASE-LINKED PRESENILIN-1 KNOCK-IN MUTATION
J. Biol. Chem., November 21, 2001; 276(48): 44736 - 44743.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (148)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cadas, H.
Right arrow Articles by Piomelli, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cadas, H.
Right arrow Articles by Piomelli, D.

-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-